TytoCare’s FDA-cleared AI devices and $25M funding highlight how remote monitoring cuts hospital visits and improves outcomes for CHF and COPD patients. AI-driven remote monitoring is shifting c...
Anthropic launched Claude Science — an AI workbench for researchers — and announced it will run its own drug-discovery programs for neglected diseases, aiming to compress R&D tenfold. What it...
A groundbreaking study in Science shows OpenAI’s o1-preview model surpasses physicians in diagnostics with limited data, yet struggles with ‘cannot-miss’ cases, suggesting a hybrid f...
Recent research identifies specific senescent cell types linked to diabetes and hypertension, enabling personalized therapies and AI-driven predictive health tools for aging populations. New studies m...
Recent studies show targeted epigenetic reprogramming with Yamanaka factors rejuvenates neurons, reversing cognitive decline in aged mice and reducing Alzheimer’s markers, with AI enhancing safe...
DeepRare, a multi-agent AI system, achieves 10% higher accuracy than expert physicians in diagnosing rare diseases, potentially reducing diagnostic delays and transforming clinical practice with trans...
A new AI system, DeepRare, demonstrates superior accuracy in diagnosing rare diseases using real-time data and self-reflective reasoning, as detailed in a 2026 Nature study, with potential to reduce d...
Advanced coronary CT scans with machine learning now quantify plaque volume more accurately than LDL levels, enabling early intervention and personalized prevention for cardiovascular disease. New AI-...
Personalized nutrition is advancing with AI and genetic testing, offering tailored diets to improve health and prevent diseases, based on recent scientific studies and new platforms. Advances in AI an...
This article analyzes the rise of digital well-being trends, including mindfulness apps and workplace initiatives, in response to increasing tech-related mental health issues, backed by recent data an...